Leukemia relapse clues: new study eyes c-Kit mutations
NCT ID NCT06116318
First seen May 16, 2026 · Last updated May 16, 2026
Summary
This study aimed to see if measuring a specific gene change (c-Kit mutation) in blood or bone marrow could help predict if acute myeloid leukemia (AML) will come back after treatment. Researchers planned to follow AML patients with this mutation and compare the new test with standard monitoring methods. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for C-KIT MUTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Hematology & Blood Diseases Hospital
Tianjin, China
Conditions
Explore the condition pages connected to this study.